Marten Steen

Directeur/Membre du Conseil chez Healthneed AB

Profil

Marten Steen is currently a Director at Healthneed AB, Vivet Therapeutics SAS, Precirix NV, Aro Biotherapeutics Co., Priothera Ltd., Hemab ApS, Mahzi Therapeutics, Inc., and Managing Partner at HealthCap AB. He previously worked as an Independent Director at Ultragenyx Pharmaceutical, Inc., Director at Cortendo AB, Director at Merck Serono SA, Director at Altimmune UK Ltd., Director at Altimmune, Inc., Director at FerroKin BioSciences, Inc., Director at Modus Therapeutics AB, Director at Rainier Therapeutics, Inc., Independent Director at Wilson Therapeutics AB, Director at Glionova AB, Independent Director at Strongbridge Biopharma Plc, and Director at ADCendo ApS.
Dr. Steen obtained his undergraduate, graduate, and doctorate degrees from the University of Lund in 2005 and 2003 respectively.

Postes actifs de Marten Steen

Sociétés	Poste	Début
HealthCap AB	Private Equity Investor	01/04/2010
Healthneed AB	Directeur/Membre du Conseil	-
Priothera Ltd.	Directeur/Membre du Conseil	-
Mahzi Therapeutics, Inc.	Directeur/Membre du Conseil	-
Hemab ApS	Directeur/Membre du Conseil	-
Aro Biotherapeutics Co.	Directeur/Membre du Conseil	-
Vivet Therapeutics SAS	Directeur/Membre du Conseil	-
Precirix NV	Directeur/Membre du Conseil	-

Anciens postes connus de Marten Steen

Sociétés	Poste	Fin
Altimmune UK Ltd.	Directeur/Membre du Conseil	06/06/2017
░░░░░░ ░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░